|
|
Miraca Holdings Incorporated - Comparative Business Analysis Snapshot
Business Description
Miraca Holdings Incorporated. The Group's principal activities are to manufacture, distribute and export and import clinical reagents, pharmaceutical items, medical instruments and medical equipment. The Group is also involved in the research and development, manufacturing, distributing, export and import of gene chips and the gene and clinical data related services. The operations are carried out through the following divisions: Clinical diagnostics; Clinical & other diagnosis and Other. The pharmaceutical items include diagnostic reagents such as AIDS and hepatitis-B diagnostic drugs.
Competitor Analysis
This analysis compares Miraca Holdings Incorporated with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
